Search results for "reparations"

showing 10 items of 367 documents

A Sensitive Nanosensor for the In Situ Detection of the Cannibal Drug.

2020

[EN] A bio-inspired nanodevice for the selective and sensitive fluorogenic detection of 3,4- methylenedioxypyrovalerone (MDPV), usually known as Cannibal drug, is reported. The sensing nanodevice is based on mesoporous silica nanoparticles (MSNs), loaded with a fluorescent reporter (rhodamine B) and functionalized on their external surface with a dopamine derivative (3), which specifically interacts with the recombinant human dopamine transporter (DAT), capping the pores. In the presence of MDPV, DAT detaches from the MSNs consequently causing rhodamine B release and allowing drug detection. The nanosensor shows a detection limit of 5.2 µM and it is able to detect the MDPV drug both in sali…

Mesoporous silica nanoparticlesDopamineNanosensorNanoparticleBioengineeringDrug detectionMDPVchemistry.chemical_compoundQUIMICA ORGANICANanosensorQUIMICA ANALITICARhodamine Brecombinant human dopamine transporterHumansmesoporous silica nanoparticlesInstrumentationNanodeviceDopamine transporterFluid Flow and Transfer ProcessesDetection limitbiologyProcess Chemistry and TechnologyQUIMICA INORGANICAMesoporous silicaSilicon DioxidechemistryPharmaceutical Preparationsbiology.proteinBiophysicsNanoparticlesRecombinant human dopamine transporter (DAT)nanosensorcannibal drugCannibal drugACS sensors
researchProduct

Quantitation of antihistamines in pharmaceutical preparations by liquid chromatography with a micellar mobile phase of sodium dodecyl sulfate and pen…

2002

Abstract A reversed-phase liquid chromatographic procedure with a micellar mobile phase of sodium dodecyl sulfate (SDS), containing a small amount of pentanol, was developed for the control of 7 antihistamines of diverse action in pharmaceutical preparations (tablets, capsules, powders, solutions, and syrups): azatadine, carbinoxamine, cyclizine, cyproheptadine, diphenhydramine, doxylamine, and tripelennamine. The retention times of the drugs were <9 min with a mobile phase of 0.15M SDS–6% (v/v) pentanol. The recoveries with respect to the declared compositions were in the range of 93–110%, and the intra- and interday repeatabilities and interday reproducibility were <1.2%. Th…

MicelleDosage formAnalytical Chemistrychemistry.chemical_compoundPentanolsmedicineCyclizineHumansEnvironmental ChemistrySodium dodecyl sulfateMicellesDosage FormsPharmacologyChromatographyChemistrySodium Dodecyl SulfatePharmaceutical PreparationsDoxylamineMicellar solutionsHistamine H1 AntagonistsCarbinoxamineAzatadineAgronomy and Crop ScienceChromatography LiquidFood Sciencemedicine.drug
researchProduct

Controlled release using mesoporous materials containing gate-like scaffoldings.

2009

The use of gated mesoporous silica solids as suitable systems for controlled-release protocols is reviewed. These materials are based on mesoporous silica supports that can be prepared with tailor-made pores of around 2 - 10 nm and that show a very large specific surface area (up to 1200 m(2)/g), thus having a large load capacity. The solids can be additionally functionalised in the external surface with gate-like systems that can be opened on command to allow cargo release. Light, redox reactions, pH, temperature, polarity and enzyme-driven protocols are shown. The possible application in drug delivery protocols is discussed.

Models MolecularDrug CarriersMaterials scienceSilicon dioxidePharmaceutical ScienceNanotechnologyMesoporous silicaSilicon DioxideControlled releaseNanostructureschemistry.chemical_compoundMesoporous organosilicaDrug Delivery SystemschemistrySpecific surface areaDelayed-Action PreparationsMesoporous materialHybrid materialDrug carrierPorosityExpert opinion on drug delivery
researchProduct

Finely Tuned Temperature-Controlled Cargo Release Using Paraffin-Capped Mesoporous Silica Nanoparticles

2011

[EN] Trapped: Mesoporous silica nanoparticles were loaded with a fluorescent guest and functionalized with octadecyltrimethoxysilane. The alkyl chains interact with paraffins, which build a hydrophobic layer around the particle (see picture). Upon melting of the paraffin, the guest molecule is released, as demonstrated in cells for the guest doxorubicin. The release temperature can be tuned by choosing an appropriate paraffin. Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Models MolecularINGENIERIA DE LA CONSTRUCCIONGuest moleculesParaffinsParaffin waxesNanoparticlemesoporous materialsMCM-41Phenazine derivativeFunctionalizedCell survivalNanoparticleQUIMICA ORGANICAChemical structureX-Ray DiffractionSafranin tSilicon dioxideControlled releaseAlkyl chainDrug CarriersMicroscopy ConfocalMolecular StructureOctadecyltrimethoxysilaneSurface propertyTemperatureSilicaGeneral MedicineChemistryAntineoplastic agentParaffinHeLa cellPorosityHumanMaterials scienceDrug carrierX ray diffractionSurface PropertiesMesoporous silica nanoparticlesNanotechnologyAntineoplastic AgentsMesoporousCatalysisDrug interactionsArticleMicroscopy Electron TransmissionHumansCell survivalDrug effectDelayed release formulationHydrophobic layersQUIMICA INORGANICAGeneral ChemistryMesoporous silicaMolecular gatesMesoporous materialsMcm 41Confocal microscopyDrug effectSolubilityDoxorubicinDelayed-Action Preparationsdrug deliveryDrug deliveryNanoparticlesPhenazinesnanoparticlesMesoporous materialcontrolled releasemolecular gatesTransmission electron microscopyHeLa CellsAngewandte Chemie
researchProduct

Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers.

2014

This communication demonstrates the possibility to nucleate and grow different crystalline polymorphic forms of gabapentin (GBP) using, as nucleation templates, Langmuir monolayers of an amphiphilic calixarene at different packing densities.

Models MolecularLangmuirCyclohexanecarboxylic AcidsNucleation02 engineering and technology010402 general chemistry01 natural sciencesCatalysisAmphiphileCalixareneMonolayerMaterials ChemistryOrganic chemistryAminesta116gamma-Aminobutyric AcidActive ingredientMolecular StructureChemistryMetals and AlloysGeneral Chemistry021001 nanoscience & nanotechnology0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsChemical engineeringPolymorphism (materials science)Pharmaceutical PreparationsCeramics and CompositesCalixarenesGabapentin0210 nano-technologyChemical communications (Cambridge, England)
researchProduct

DNA minor groove binders: an overview on molecular modeling and QSAR approaches

2007

Molecular recognition of DNA by small molecules and proteins is a fundamental problem in structural biology and drug design. Understanding of recognition in both sequence-selective and sequence neutral ways at the level of successful prediction of binding modes and site selectivity will be instrumental for improvements in the design and synthesis of new molecules as potent and selective gene-regulatory drugs. Minor groove is the target of a large number of non-covalent binding agents. DNA binding with specific sequences, mostly AT, takes place by means of a combination of directed hydrogen bonding to base pair edges, van der Waals interactions with the minor groove walls and generalized ele…

Models MolecularPharmacologyDNA minor groove binders (mGBs) in silico techniques molecular modeling ab initio methods docking molecular dynamics simulations (MDS) QSAR QSPR.Molecular modelBase pairStereochemistryChemistryIn silicoOrganic ChemistryQuantitative Structure-Activity RelationshipDNAComputational biologyBiochemistrySmall moleculechemistry.chemical_compoundMolecular recognitionPharmaceutical PreparationsStructural biologyDocking (molecular)Drug DesignDrug DiscoveryNucleic Acid ConformationMolecular MedicineDNA
researchProduct

Pharmacy and pharmacology of biosimilars

2008

Biosimilar medicines are biological medicinal products that can obtain a marketing authorization in the EU after the original product (biological reference medicine) has run out of patent. As a prerequisite, studies including clinical trials are to be conducted to compare the quality, safety, and efficacy of the biosimilar and reference medicine. Due to the specific characteristics of biopharmaceuticals like complex 3-dimensional (glyco) protein structure, immunogenicity, production in living organisms, which causes heterogeneity, complex manufacturing process and analysis, interchangeability of the biosimilar with its reference drug product is not guaranteed. In addition, INN (internationa…

Models MolecularQuality ControlDrug IndustryTraceabilityEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectPharmacyPharmacyPharmacologyMarketing authorizationInterchangeabilityEndocrinologyPharmacovigilanceHumansMedicineQuality (business)media_commonPharmacologybusiness.industryBiosimilarProduct (business)Pharmaceutical PreparationsTherapeutic EquivalencyImmune SystembusinessAlgorithmsJournal of Endocrinological Investigation
researchProduct

On the contribution of molecular topology to drug design and discovery.

2010

Abstract The role of molecular topology (MT) in the design and selection of new drugs is discussed. After an overview of the different in silico molecular design current technologies, the QSAR analysis is dealt in detail with particular emphasis in the use of topological indices as molecular descriptors. The results of the application of MT in drug design and discovery are described and finally a possible explanation is given about some of the key reasons explaining it's the extraordinary performance.

Models MolecularQuantitative structure–activity relationshipTheoretical computer scienceComputer scienceIn silicoQuantitative Structure-Activity RelationshipGeneral MedicinePharmaceutical PreparationsMolecular descriptorDrug DesignDrug DiscoveryMolecular MedicineAnimalsComputer-Aided DesignHumansComputer SimulationMolecular topologyCurrent computer-aided drug design
researchProduct

General topological patterns of known drugs.

2001

Abstract Discriminating “drug-like” from “non-drug-like” compounds is a relatively emerging topic within the drug research. The basic assumption is that it is possible to obtain relevant information from structural features common to the known drugs, in order to discard a huge number of candidate chemical structures with low probability of becoming drugs. A graph-theoretical contribution to this subject is reported in this paper, by making exclusive use of linear relationships. The results suggest that it is possible to achieve a pattern of general pharmacological activity based on molecular topology. Conclusions are tentative pending verification of the results with larger compound librari…

Models MolecularTheoretical computer scienceMolecular StructureChemistryStereochemistryComputer Graphics and Computer-Aided DesignStructure-Activity RelationshipPharmaceutical PreparationsDrug DesignMaterials ChemistryPhysical and Theoretical ChemistryMolecular topologyRelevant informationSpectroscopyTopology (chemistry)Journal of molecular graphicsmodelling
researchProduct

Permutation Test (PT) and Tolerated Difference Test (TDT): Two new, robust and powerful nonparametric tests for statistical comparison of dissolution…

2013

The most popular way of comparing oral solid forms of drug formulations from different batches or manufacturers is through dissolution profile comparison. Usually, a similarity factor known as (f2) is employed; However, the level of confidence associated with this method is uncertain and its statistical power is low. In addition, f2 lacks the flexibility needed to perform in special scenarios. In this study two new statistical tests based on nonparametrical Permutation Test theory are described, the Permutation Test (PT), which is very restrictive to confer similarity, and the Tolerated Difference Test (TDT), which has flexible restrictedness to confer similarity, are described and compared…

Models StatisticalNonparametric statisticsAdministration OralPharmaceutical ScienceSampling (statistics)Models TheoreticalStatistics NonparametricStatistical powerConfidence intervalPharmaceutical PreparationsSolubilitySimilarity (network science)Robustness (computer science)ResamplingStatisticsComputer SimulationMathematicsStatistical hypothesis testingInternational Journal of Pharmaceutics
researchProduct